News & Events

Cellular Dynamics to Present at Leerink Global Healthcare Conference

Download PDF

MADISON, Wis., Feb. 3, 2015 (GLOBE NEWSWIRE) — Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink Global Healthcare Conference held February 11-12, 2015, in New York City.

The following are specific details regarding CDI’s presentation:

Date: February 11, 2015
Time: 1:50 pm ET
Webcast: The live webcast can be accessed via the Investor Relations section of CDI’s website at within Events & Presentations. The archived audio webcast will be available on the Company’s website for 90 days following the presentation.
Location: Waldorf Astoria, NYC

About Cellular Dynamics International, Inc.

Cellular Dynamics International, Inc. (CDI) is a leading developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications. CDI’s proprietary iCell Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI’s iCell O/S products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in the research and development of cellular therapeutics. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of WisconsinMadison. CDI’s facilities are located in Madison, Wisconsin, with a second facility in Novato, California. See


Joleen Rau Senior Director, Investor Relations & Corporate Communications
Cellular Dynamics International, Inc.

(608) 310-5142

Investor Relations

Gitanjali Jain Ogawa The Trout Group, LLC
(646) 378-2949

Source: Cellular Dynamics International, Inc.